Business
Bleepa-CareLocker contract extension with QVH
Bleepa-CareLocker contract extension with QVH.
About this update from Feedback Plc
[{"type":"text","content":"\n \n \n Feedback plc\n \n \n \n \n \n \n \n \n Bleepa-CareLocker contract extension with Queen Victoria Hospital\n \n \n \n \n \n \n \n \n Feedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the specialist clinical communication company, announces that it has been awarded a nine-month, fixed-term contract extension of its contract for the Sussex Health and Care Partnership Integrated Care System (\"Sussex ICS\") development programme with Queen Victoria Hospital (\"QVH\") for Feedback's Bleepa-CareLocker Community Diagnostics Centre (\"CDC\") solution.\n \n \n \n \n \n This paid extension, which follows the success of the Company's existing contract (details of which were announced by Feedback on 6 September 2022), follows the abandonment of the Trust's previous procurement process in March 2023 and will cover the period from 1 April 2023 until 31 December 2023 whilst QVH undertakes a new tender exercise under the Public Contracts Regulations 2015. A new tender process for the next phase of the CDC programme rollout is due to commence imminently.\n \n \n \n \n \n QVH is expected to procure the relevant components of the CDC programme, including the digital pathway element, currently under contract with Feedback.\n \n \n \n \n \n \n Dr Tom Oakley, CEO Feedback plc said:\n \n \"Although QVH had expected to conclude its tender process by 31st March 2023, we have been informed by the Trust that the existing tender process is no longer progressing. We are pleased to be supporting QVH on an interim basis to ensure the continuity of ongoing patient care whist they undertake a further procurement exercise.\n \n \n \n \n \n \n \n \n \"The digital component of CDC delivery\n \n \n that Feedback provides is critical, and we continue to champion the QVH CDC programme to other NHS organisations through the continuation of this contract, and remain confident in the emerging opportunity that CDCs represent both for the Company and the wider NHS. While we continue to support QVH, the Company will actively explore opportunities to support the wider CDC capability throughout the NHS.\"\n \n \n \n \n \n \n This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018.\n \n \...